Small Cell Lung Cancer (SCLC)Fase 2NCT07149363
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Durvalumab 50 MG/ML
73 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Pulmón y tórax73 estudios
Small Cell Lung Cancer (SCLC)Fase 2NCT07149363
Durvalumab 50 MG/ML
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorFase 2NCT07874490
Osimertinib, Cyclosporine A (CsA), ctDNA Biopsy Panel
Cáncer de pulmón no microcíticoFase 2NCT04302025
Alectinib, Entrectinib, Vemurafenib, Cobimetinib
Cáncer de pulmón no microcíticoFase 2NCT01639508Artículos
Cabozantinib
Advanced Lung Non-Small Cell CarcinomaFase 2NCT07322341
Atezolizumab, CXCR1/2 Inhibitor SX-682, Biospecimen Collection, Computed Tomography
Recurrent Lung Non-Small Cell CarcinomaFase 2NCT07393555
Biospecimen Collection, Computed Tomography, Ivonescimab, Magnetic Resonance Imaging
Carcinoma de pulmón no microcíticoFase 2NCT06116682
Amivantamab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging
Cáncer de pulmón microcítico en estadio extendidoFase 2NCT05588388
Bevacizumab
Lung NeoplasmFase 2NCT06780098
R-DXD, I-DXD, Docetaxel, Rescue Medications
Non-small Cell Lung Cancer Stage IIIFase 2NCT06449313
Cemiplimab-Rwlc
Non-small Cell Lung Cancer (NSCLC)Fase 2NCT07288177
Rina-S
Thymus CarcinomaFase 2NCT06980077
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ivonescimab
Cáncer de pulmón no microcíticoFase 2NCT06907615
HLX43 DOSE 1 (2.0 mg/kg), HLX43 DOSE 2 (2.5 mg/kg)
Carcinoma, Non-small-Cell LungFase 2NCT05498428
Amivantamab, Lazertinib, Carboplatin, Pemetrexed
Carcinoma, Non-Small-Cell LungFase 2NCT06667076
Amivantamab, Lazertinib, Chemotherapy: Pemetrexed, Chemotherapy: Carboplatin
Carcinoma, Non-Small-Cell LungFase 2NCT06667908
JNJ-90301900, Durvalumab, Concurrent Chemo/Radiation Therapy (cCRT), Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin
Carcinoma, Non-Small-Cell LungFase 2NCT07586202
Amivantamab, Lazertinib, Carboplatin, Pemetrexed
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)Fase 2NCT06693336
SMS001
Squamous Cell Lung CancerFase 2NCT05607108
ZEN003694
Cáncer de pulmón no microcíticoFase 2NCT06745882
Cisplatin, Carboplatin, Pemetrexed, Pembrolizumab
Carcinoma, Non-Small-Cell LungFase 2NCT06855771
BMS-986504, Izalontamab Brengitecan
Cáncer de pulmón microcítico en estadio extendidoFase 2NCT07459634
Lurbinectedin, Durvalumab
Resectable Lung Non-Small Cell CarcinomaFase 2NCT06008730
Biospecimen Collection, Proton Beam Radiation Therapy, Radiology, Treatment Planning
Lung CancerFase 2NCT07630168
PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM, PD-1/PD-L1 inhibitor monotherapy - 4 cycles after 3 PM, PD-1 inhibitor monotherapy - 2 cycles before 12:00PM, PD-1 inhibitor monotherapy - 2 cycles after 3 PM